$2103.91
4.340.21%
al cierre: -
$2103.90
-0.010000.00%
After hour: 7:55 PM EDT
Comments
Loading...
Calificaciones de analistas, precios objetivo, pronóstico
MercadoLibre Inc tiene un precio objetivo de consenso de $2710 basado en las calificaciones de 21 analistas. El máximo es $3500, emitido por Scotiabank el julio 28, 2025. El mínimo es $1650, emitido por New Street Research el septiembre 1, 2023. Las 3 calificaciones de analistas más recientes fueron publicadas por Morgan Stanley, JP Morgan y Benchmark el noviembre 3, 2025, noviembre 3, 2025 y octubre 30, 2025, respectivamente. Con un precio objetivo promedio de $2793.33 entre Morgan Stanley, JP Morgan y Benchmark, hay una 32.77% upside implícita para MercadoLibre Inc según estas calificaciones más recientes de analistas.
Firmas de analistas que realizan recomendaciones1
Morgan Stanley
JP Morgan
Benchmark
Barclays
Cantor Fitzgerald
1calculado a partir de las calificaciones de los analistas
Calificaciones de analistas para MercadoLibre
Buy Now | Get Alert | |||||||
|---|---|---|---|---|---|---|---|---|
11/03/2025 | 40.22% | Morgan Stanley | $2850 → $2950 | Maintains | Overweight | |||
11/03/2025 | 25.96% | JP Morgan | $2600 → $2650 | Maintains | Neutral | |||
10/30/2025 | 32.14% | Benchmark | $2875 → $2780 | Maintains | Buy | |||
10/30/2025 | 37.84% | Barclays | $2800 → $2900 | Maintains | Overweight | |||
10/30/2025 | 30.71% | Cantor Fitzgerald | $2900 → $2750 | Maintains | Overweight | |||
10/21/2025 | 36.65% | Benchmark | $2875 → $2875 | Reiterates | Buy → Buy | |||
10/21/2025 | 33.09% | Barclays | $3000 → $2800 | Maintains | Overweight | |||
10/13/2025 | 37.84% | Susquehanna | $2975 → $2900 | Maintains | Positive | |||
10/09/2025 | 28.33% | Citigroup | $2850 → $2700 | Maintains | Buy | |||
10/03/2025 | 23.58% | JP Morgan | $2700 → $2600 | Maintains | Neutral | |||
09/24/2025 | 37.84% | Cantor Fitzgerald | $2700 → $2900 | Maintains | Overweight | |||
08/18/2025 | 35.46% | Citigroup | $2900 → $2850 | Maintains | Buy | |||
08/07/2025 | 28.33% | JP Morgan | $2600 → $2700 | Maintains | Neutral | |||
08/05/2025 | 36.65% | Benchmark | $2875 → $2875 | Reiterates | Buy → Buy | |||
08/05/2025 | 28.33% | Cantor Fitzgerald | $2700 → $2700 | Reiterates | Overweight → Overweight | |||
08/05/2025 | 30.71% | Raymond James | $2750 → $2750 | Reiterates | Strong Buy → Strong Buy | |||
08/05/2025 | 28.33% | Wedbush | $2800 → $2700 | Maintains | Outperform | |||
08/05/2025 | 33.09% | Jefferies | $2800 → $2800 | Maintains | Hold | |||
08/01/2025 | 42.59% | Daiwa Capital | → $3000 | Initiates | → Buy | |||
07/28/2025 | 66.36% | Scotiabank | → $3500 | Initiates | → Sector Outperform | |||
07/23/2025 | 42.59% | Barclays | $3100 → $3000 | Maintains | Overweight | |||
07/17/2025 | 37.84% | Citigroup | $3000 → $2900 | Maintains | Buy | |||
06/26/2025 | 41.4% | Susquehanna | $2840 → $2975 | Maintains | Positive | |||
06/11/2025 | 28.33% | Cantor Fitzgerald | $2900 → $2700 | Maintains | Overweight | |||
06/05/2025 | 33.09% | Jefferies | $2450 → $2800 | Downgrade | Buy → Hold | |||
05/22/2025 | 23.58% | JP Morgan | $2250 → $2600 | Maintains | Neutral | |||
05/14/2025 | 42.59% | Goldman Sachs | $2640 → $3000 | Maintains | Buy | |||
05/08/2025 | 37.84% | Cantor Fitzgerald | $2400 → $2900 | Maintains | Overweight | |||
05/08/2025 | 47.35% | Barclays | $2500 → $3100 | Maintains | Overweight | |||
04/16/2025 | 14.07% | Cantor Fitzgerald | $3000 → $2400 | Maintains | Overweight | |||
04/15/2025 | 18.83% | Benchmark | → $2500 | Initiates | → Buy | |||
04/10/2025 | 21.68% | Morgan Stanley | $2650 → $2560 | Maintains | Overweight | |||
04/07/2025 | 6.94% | JP Morgan | $2300 → $2250 | Maintains | Neutral | |||
03/04/2025 | 16.45% | Jefferies | $2250 → $2450 | Maintains | Buy | |||
03/03/2025 | 30.71% | Goldman Sachs | $2400 → $2750 | Maintains | Buy | |||
02/25/2025 | 9.32% | JP Morgan | $1950 → $2300 | Maintains | Neutral | |||
02/24/2025 | 25.96% | Morgan Stanley | $2400 → $2650 | Maintains | Overweight | |||
02/21/2025 | 42.59% | Cantor Fitzgerald | $2150 → $3000 | Maintains | Overweight | |||
02/21/2025 | 31.18% | Susquehanna | $2350 → $2760 | Maintains | Positive | |||
02/21/2025 | 42.59% | B of A Securities | $2500 → $3000 | Maintains | Buy | |||
02/21/2025 | 18.83% | Barclays | $2200 → $2500 | Maintains | Overweight | |||
01/21/2025 | 6.94% | Raymond James | $2250 → $2250 | Upgrade | Outperform → Strong Buy | |||
01/10/2025 | 14.07% | Morgan Stanley | $2450 → $2400 | Maintains | Overweight | |||
01/08/2025 | -7.31% | JP Morgan | $2150 → $1950 | Maintains | Neutral | |||
01/07/2025 | 2.19% | Cantor Fitzgerald | $2300 → $2150 | Maintains | Overweight | |||
01/06/2025 | -0.19% | Wedbush | $2200 → $2100 | Maintains | Outperform | |||
11/26/2024 | 16.45% | Citigroup | $2480 → $2450 | Maintains | Buy | |||
11/13/2024 | 2.19% | JP Morgan | $2400 → $2150 | Maintains | Neutral | |||
11/12/2024 | 4.57% | Barclays | $2500 → $2200 | Maintains | Overweight | |||
11/11/2024 | 16.45% | Morgan Stanley | $2500 → $2450 | Maintains | Overweight | |||
11/07/2024 | 4.57% | BTIG | $2250 → $2200 | Maintains | Buy | |||
11/07/2024 | 9.32% | Cantor Fitzgerald | $2530 → $2300 | Maintains | Overweight | |||
10/31/2024 | 14.07% | UBS | $2300 → $2400 | Maintains | Buy | |||
10/22/2024 | 17.88% | Citigroup | $2200 → $2480 | Maintains | Buy | |||
10/11/2024 | 33.09% | Redburn Atlantic | → $2800 | Initiates | → Buy | |||
10/02/2024 | 18.83% | Barclays | $2100 → $2500 | Maintains | Overweight | |||
10/02/2024 | 14.07% | JP Morgan | $2400 → $2400 | Downgrade | Overweight → Neutral | |||
09/27/2024 | 11.7% | Raymond James | → $2350 | Initiates | → Outperform | |||
09/23/2024 | 20.25% | Cantor Fitzgerald | $2530 → $2530 | Reiterates | Overweight → Overweight | |||
09/20/2024 | 18.83% | Morgan Stanley | $2175 → $2500 | Maintains | Overweight | |||
09/12/2024 | 18.83% | B of A Securities | $2250 → $2500 | Maintains | Buy | |||
09/05/2024 | 20.25% | Cantor Fitzgerald | → $2530 | Initiates | → Overweight | |||
08/28/2024 | 11.7% | Susquehanna | $2300 → $2350 | Maintains | Positive | |||
08/27/2024 | 6.94% | Jefferies | $2100 → $2250 | Maintains | Buy | |||
08/23/2024 | 9.32% | UBS | $2000 → $2300 | Maintains | Buy | |||
08/21/2024 | 6.94% | BTIG | $2025 → $2250 | Maintains | Buy | |||
08/19/2024 | 9.32% | Susquehanna | $2000 → $2300 | Maintains | Positive | |||
08/15/2024 | 4.57% | Citigroup | $2000 → $2200 | Maintains | Buy | |||
08/08/2024 | 17.88% | Goldman Sachs | $2180 → $2480 | Maintains | Buy | |||
08/06/2024 | 14.07% | JP Morgan | $2150 → $2400 | Maintains | Overweight | |||
08/06/2024 | -0.19% | Barclays | $2000 → $2100 | Maintains | Overweight | |||
08/02/2024 | -3.75% | BTIG | $1885 → $2025 | Maintains | Buy | |||
07/19/2024 | -4.94% | UBS | $1950 → $2000 | Maintains | Buy | |||
06/07/2024 | -7.31% | UBS | $1800 → $1950 | Maintains | Buy | |||
05/20/2024 | -0.19% | Jefferies | → $2100 | Upgrade | Hold → Buy | |||
05/13/2024 | -4.94% | Barclays | $1800 → $2000 | Maintains | Overweight | |||
05/03/2024 | -14.44% | Wedbush | $1800 → $1800 | Reiterates | Outperform → Outperform | |||
04/24/2024 | -14.44% | Wedbush | $2000 → $1800 | Maintains | Outperform | |||
04/17/2024 | -14.44% | UBS | $1900 → $1800 | Maintains | Buy | |||
04/03/2024 | -14.44% | Barclays | $2000 → $1800 | Maintains | Overweight | |||
03/27/2024 | -7.79% | Citigroup | $1990 → $1940 | Maintains | Buy | |||
03/06/2024 | -4.94% | Wedbush | $2000 → $2000 | Reiterates | Outperform → Outperform | |||
03/05/2024 | -4.94% | Wedbush | $2000 → $2000 | Reiterates | Outperform → Outperform | |||
02/27/2024 | 2.19% | JP Morgan | $2000 → $2150 | Maintains | Overweight | |||
02/23/2024 | -4.94% | Barclays | $1900 → $2000 | Maintains | Overweight | |||
02/23/2024 | -4.94% | Susquehanna | $1850 → $2000 | Maintains | Positive | |||
02/23/2024 | -4.94% | Wedbush | $1800 → $2000 | Maintains | Outperform | |||
01/03/2024 | -9.69% | Citigroup | $1550 → $1900 | Maintains | Buy | |||
12/27/2023 | -14.44% | Wedbush | $1700 → $1800 | Maintains | Outperform | |||
11/28/2023 | -12.07% | Susquehanna | $1625 → $1850 | Maintains | Positive | |||
11/02/2023 | -28.7% | Wedbush | → $1500 | Reiterates | Outperform → Outperform | |||
09/18/2023 | -22.76% | Susquehanna | $1500 → $1625 | Maintains | Positive | |||
09/01/2023 | -21.57% | New Street Research | → $1650 | Upgrade | Neutral → Buy | |||
08/30/2023 | -19.2% | UBS | $1600 → $1700 | Maintains | Buy | |||
08/22/2023 | -28.7% | Wedbush | → $1500 | Initiates | → Outperform | |||
08/09/2023 | 3.62% | Goldman Sachs | $1910 → $2180 | Maintains | Buy | |||
08/08/2023 | -22.76% | Barclays | $1575 → $1625 | Maintains | Overweight | |||
08/07/2023 | -4.94% | JP Morgan | $1700 → $2000 | Maintains | Overweight | |||
08/03/2023 | -15.4% | Credit Suisse | $1760 → $1780 | Maintains | Outperform | |||
07/31/2023 | -16.35% | Credit Suisse | $1730 → $1760 | Maintains | Outperform |
PREGUNTAS FRECUENTES
¿Cuál es el precio objetivo de las acciones de MercadoLibre (MELI)?
El último precio objetivo de MercadoLibre (NASDAQ:MELI) fue comunicado por Morgan Stanley el noviembre 3, 2025. La firma de analistas fijó un precio objetivo para $2950.00 que espera MELI a rise dentro de 12 meses (un posible 40.22% upside). 47 firmas de analistas han reportado calificaciones en el último año.
¿Cuál es la calificación más reciente de los analistas sobre MercadoLibre (MELI)?
La última calificación de analistas para MercadoLibre (NASDAQ:MELI) fue proporcionada por Morgan Stanley, y MercadoLibre mantuvo su overweight calificación.
¿Cuándo se produjo la última revisión al alza de MercadoLibre (MELI)?
La última revisión al alza de MercadoLibre Inc se produjo en enero 21, 2025, cuando Raymond James elevó su precio objetivo a $2250. Raymond James anteriormente tenía an outperform para MercadoLibre Inc.
¿Cuándo fue la última revisión a la baja de MercadoLibre (MELI)?
La última revisión a la baja de MercadoLibre Inc se produjo en junio 5, 2025, cuando Jefferies cambió su precio objetivo de $2450 a $2800 para MercadoLibre Inc.
¿Cuándo se publicará o actualizará la próxima calificación de los analistas para MercadoLibre (MELI)?
Los analistas llegan a las calificaciones de acciones después de hacer una investigación exhaustiva, que incluye revisar los estados financieros públicos, hablar con ejecutivos y clientes de MercadoLibre, y escuchar las teleconferencias de ganancias. La mayoría de los analistas hacen esto cada tres meses, por lo que deberías recibir 4 calificaciones por empresa al año. La última calificación de MercadoLibre se registró el noviembre 3, 2025, por lo que la próxima calificación estará disponible en torno al noviembre 3, 2026.
¿Es correcta la calificación de los analistas sobre MercadoLibre (MELI)?
Aunque las calificaciones son subjetivas y pueden cambiar, la última calificación de MercadoLibre (MELI) fue un mantuvo con un precio objetivo de $2850.00 a $2950.00. El precio actual al que cotiza MercadoLibre (MELI) es de $2103.90, que es out of del rango previsto por el analista.
Explora calificaciones de analistas y precios objetivo sobre todos los valores.